Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
26.60
-1.98 (-6.93%)
Jun 1, 2026, 4:08 PM HKT
| Market Cap | 3.62B |
| Revenue (ttm) | 102.38K -95.8% |
| Net Income | -145.79M |
| EPS | -1.24 |
| Shares Out | 136.22M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 132,000 |
| Open | 29.20 |
| Previous Close | 28.58 |
| Day's Range | 26.40 - 29.20 |
| 52-Week Range | 13.48 - 32.94 |
| Beta | 0.84 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 27, 2026 |